Location: Biologics Development Module
Project Number: 3022-32000-026-021-S
Project Type: Non-Assistance Cooperative Agreement
Start Date: Sep 3, 2025
End Date: Aug 1, 2026
Objective:
To determine variable domains of hybridomas with potential for commercial development and obtain purified antibody of sufficient quantity for testing and evaluation as a reagent in antibody dependent assay
Approach:
Hybridoma cells will be shared with the cooperator. The cooperator will culture cells for variable domain sequencing and antibody production followed by purification of antibody reagents.Hybridoma cells will be shared with the cooperator. The cooperator will culture cells for variable domain sequencing and antibody production followed by purification of antibody reagents.